Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao(The Affiliated Yongchuan Hospital of Chongqing Medical University), Michelle Haber(Cancer Clinic)
Cited by 31
Related Papers
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
|Frontiers in Oncology|2022|13
Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia
|Leukemia|2016|10
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
|Journal of Experimental & Clinical Cancer Research|2025|1
24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesis
|European Journal of Cancer|2024|0